Evidence map›Paper›PMID 33284805›Full record

Observational studyPLoS medicine2020

Antenatal corticosteroid administration and early school age child development: A regression discontinuity study in British Columbia, Canada.

Jennifer A Hutcheon, Sam Harper, Jessica Liauw, M Amanda Skoll, Myriam Srour, Erin C Strumpf

Abstract readObservational Study
In one paragraph

Observational study in PLoS medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Recent research on the effect of common treatments given in the perinatal period on neurodevelopment in offspring.Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2022
    Review
  12. Antenatal corticosteroid administration and attention-deficit/hyperactivity disorder in childhood: a regression discontinuity study.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jennifer A HutcheonDepartment of Obstetrics & Gynaecology, University of British Columbia, Vancouver, Canada.ORCID 0000-0002-6618-6018
Sam HarperDepartment of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Canada.ORCID 0000-0002-2767-1053
Jessica LiauwDepartment of Obstetrics & Gynaecology, University of British Columbia, Vancouver, Canada.ORCID 0000-0002-1573-5574
M Amanda SkollDepartment of Obstetrics & Gynaecology, University of British Columbia, Vancouver, Canada.ORCID 0000-0001-5413-9102
Myriam SrourDepartments of Pediatrics and of Neurology and Neurosurgery, McGill University, Montreal, Canada.
Erin C StrumpfDepartment of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Canada.

Funding

CIHR
6 · The paper itself

Abstract

backgroundThere are growing concerns that antenatal corticosteroid administration may harm children's neurodevelopment. We investigated the safety of antenatal corticosteroid administration practices for children's overall developmental health (skills and behaviors) at early school age. METHODS AND

findingsWe linked population health and education databases from British Columbia (BC), Canada to identify a cohort of births admitted to hospital between 31 weeks, 0 days gestation (31+0 weeks), and 36+6 weeks, 2000 to 2013, with routine early school age child development testing. We used a regression discontinuity design to compare outcomes of infants admitted just before and just after the clinical threshold for corticosteroid administration of 34+0 weeks. We estimated the median difference in the overall Early Development Instrument (EDI) score and EDI subdomain scores, as well as risk differences (RDs) for special needs designation and developmental vulnerability (<10th percentile on 2 or more subdomains). The cohort included 5,562 births admitted between 31+0 and 36+6 weeks, with a median EDI score of 40/50. We found no evidence that antenatal corticosteroid administration practices were linked with altered child development at early school age: median EDI score difference of -0.5 [95% CI: -2.2 to 1.7] (p = 0.65), RD per 100 births for special needs designation -0.5 [-4.2 to 3.1] (p = 0.96) and for developmental vulnerability of 3.9 [95% CI:-2.2 to 10.0] (p = 0.24). A limitation of our study is that the regression discontinuity design estimates the effect of antenatal corticosteroid administration at the gestational age of the discontinuity, 34 + 0 weeks, so our results may become less generalisable as gestational age moves further away from this point.

conclusionsOur study did not find that that antenatal corticosteroid administration practices were associated with child development at early school age. Our findings may be useful for supporting clinical counseling about antenatal corticosteroids administration at late preterm gestation, when the balance of harms and benefits is less clear.

Indexed as

Child BehaviorChild DevelopmentMaternal ExposurePrenatal CareAdrenal Cortex HormonesAge FactorsAttentionBritish ColumbiaChildChild, PreschoolDrug Administration ScheduleEmotionsFemaleGestational AgeHumansInfant, NewbornAdrenal Cortex Hormones

Identifiers

PMID33284805
PMCPMC7721186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.